Neurodegenerative diseases: Difference between revisions
Jump to navigation
Jump to search
Jensflorian (talk | contribs) →Tauopathies: GGT added |
Jensflorian (talk | contribs) →Tauopathies: CBD added |
||
| Line 522: | Line 522: | ||
==Argyrophilic grain disease== | ==Argyrophilic grain disease== | ||
==Corticobasal degeneration== | |||
*AKA '''CBD'''. | |||
*Symptoms may vary: | |||
**Progressive asymmetrical rigidity and apraxia, progressive aphasia or dementia. | |||
*Neuronal and glial Tau-positive inclusions.<ref>{{Cite journal | last1 = Dickson | first1 = DW. | last2 = Bergeron | first2 = C. | last3 = Chin | first3 = SS. | last4 = Duyckaerts | first4 = C. | last5 = Horoupian | first5 = D. | last6 = Ikeda | first6 = K. | last7 = Jellinger | first7 = K. | last8 = Lantos | first8 = PL. | last9 = Lippa | first9 = CF. | title = Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. | journal = J Neuropathol Exp Neurol | volume = 61 | issue = 11 | pages = 935-46 | month = Nov | year = 2002 | doi = | PMID = 12430710 }}</ref> | |||
**Astrocytic plaques. | |||
**Thread-like lesions | |||
*Pathology is cortical and striatal and Gallyas-positive. | |||
*Neuronal loss in the substantia nigra. | |||
==Globular glial tauopathies== | ==Globular glial tauopathies== | ||